Imperial Brands PLC ADR IMBBY

Morningstar Rating
Add To Portfolio
|%
Chart Data Not Available
  • Last Close
  • Sector
  • Industry
  • Investment Style
    Large Value
  • Market Cap
  • Forward Div Yield
    8.67%
  • Trailing Div Yield
  • Price/Sales
    0.69
  • Price/Book
    3.95
  • Beta (5-Year)
    0.54
  • Consensus Forward P/E
    8.21
  • Trailing 12-mo Rev

Morningstar's Analysis

Valuation Nov 20, 2024
Currency in USD
Is it the right time to buy or sell?
Fair ValueLearn Moreplay
1-Star Price
Premium
Economic Moat
Premium
5-Star Price
Premium
Capital Allocation
Premium
Imperial Brands: Capital Markets Day Continues Challenger Strategy Into 2030
Author Photo
Kristoffer Inton
Strategist
Analyst Note | by Kristoffer Inton Updated Mar 27, 2025

Imperial Brands provided an updated strategy focused on its approach as a challenger to its larger global peers. Operationally, it expects to focus on maintaining tobacco growth in its five core markets and building scale in next-generation products, or NGP.

Business Strategy and Outlook | by Kristoffer Inton Updated Nov 20, 2024

Imperial Brands is at the end of a five-year strategic plan launched in 2021 that looked to position the firm as a fast follower in next-generation products while strengthening its share in its most important markets. This makes sense, given its relatively smaller size to peers like Philip Morris International and British American Tobacco, which le

Morningstar Fair Value Estimate
The Morningstar Fair Value Estimate guides investors to the long-term, intrinsic value of a stock, helping them see beyond the present market price.

Show me how fair value is derived (00:41)

Morningstar calculates the fair value estimate of a company based on a projection of how much cash the company will generate in the future. Morningstar analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. The analyst discounts future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights.

The Morningstar Fair Value Estimate is a projection/opinion and not a statement of fact. If Morningstar's base-case assumptions are true the market price will converge on Morningstar's fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in the future and is no indication of future performance.

Morningstar Equity Research Methodology

Price vs. Fair Value

 
Price/Fair Value
Total Return %
Index Total Return %
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 YTD
27.28 -13.87 2.94 -22.82 -10.25 -6.87 13.67 21.42 0.45 45.71 16.46
0.37 17.15 13.16 -9.27 18.57 -11.45 18.43 1.25 7.75 9.94 5.60

Related

Morningstar Research
© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy       Disclosures        Accessibility